Sep 03 2026 eGenesis Announces Clinical Update in Ongoing Expanded Access Study of EGEN-2784 in Patients with Kidney Failure Kidney FDA
Jun 22 2026 eGenesis Appoints Glenn S. Vraniak as Chief Financial Officer and Jennifer Bergheiser as Chief Commercial Officer Company
Jun 18 2026 eGenesis to Participate at BIO International Convention 2026 Panel on the Future of Xenotransplantation Company
Mar 24 2026 eGenesis Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 Company
Sep 08 2025 eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant and Landmark Patient Updates in Ongoing Expanded Access Study Kidney FDA
Sep 03 2026 In a First, a Pig Kidney Kept a Patient Alive Until He Got a Human One. Opens in a new tab. The New York Times The New York Times
Sep 03 2026 A Transplanted Pig Kidney Is Still Working After a Record-Setting 9 Months in a Patient. Opens in a new tab. WIRED
Sep 03 2026 Pig kidney works in human body for 271 days — is this the future of organ transplants?. Opens in a new tab. BBC
Sep 03 2026 Recipients of gene-edited pig kidneys successfully receive human organs. Opens in a new tab. STAT STAT
Mar 24 2026 This startup’s gene-edited pig kidneys are already in humans — and showing promise. Opens in a new tab. Fast Company Fast Company
